TOC Analyzers from Neuronbc Enable Reliable Testing as ISPE Sampling Guide Reinforces Quality Philosophies for Pharmaceutical Water Systems

Recently, the International Society for Pharmaceutical Engineering (ISPE) released the second edition of Good Practice Guide: Sampling for Pharmaceutical Water, Steam, and Process Gases. This document delivers industry practice references for pharmaceutical enterprises to implement sampling management of utility systems.

Centered on sampling strategies, sampling point design, sampling devices and operational specifications for pharmaceutical water, steam and process gas systems, the guide highlights the significance of scientific and rational sampling practices for enhancing the reliability of analytical results. For pharmaceutical manufacturers, pharmaceutical water systems constitute a vital component of the drug production quality control system. Whether it is Purified Water (PW), Water for Injection (WFI), clean steam or relevant process gases, their quality status must be verified via a scientific and continuous monitoring system.

Among numerous water quality testing indicators, Total Organic Carbon (TOC), a key parameter for assessing organic contamination levels in water, has been widely adopted in pharmaceutical water quality control. The ISPE guide emphasizes that sampling procedures exert a substantial impact on the reliability of analytical results. Whether testing data truthfully reflects system operating conditions depends not only on the detection capability of analytical instruments but also on whether samples are representative. Accordingly, pharmaceutical enterprises shall establish appropriate sampling strategies based on water system configuration, operation modes and monitoring objectives to ensure collected samples mirror actual operating conditions. This philosophy is highly relevant to TOC testing applications. TOC analysis evaluates organic contamination within water systems by measuring total organic carbon concentrations in water samples, generating data to support enterprises in tracking water quality trends and conducting quality control. Nevertheless, the reliability of TOC test results is determined not merely by analytical instruments but also subject to sample collection procedures.

1. Scientific Sampling Improves Reliability of TOC Testing Data

Pharmaceutical water features high purity with low TOC concentrations, imposing stringent requirements on sample integrity and operational standards during testing. In practice, organic matter in water samples may stem from raw water residuals, water treatment processes, leachables from system components and microbial metabolites. Through TOC testing, manufacturers can continuously monitor trends in organic contamination of water systems and comprehensively evaluate system status combined with other quality indicators. However, if sampling locations fail to represent system operating conditions, or samples are affected by external factors during collection, storage and handling, test results may inaccurately reflect actual water quality. For instance, irrational sampling pipeline design, contaminated sampling components and high background values of sample containers can all skew testing data. Therefore, establishing a risk management-based sampling system lays a critical foundation for ensuring practically meaningful TOC test results. Proper selection of sampling points, optimized sampling device design and standardized sample collection workflows can mitigate external interferences and improve the credibility of water quality monitoring data.

2. ISPE Sampling Philosophy Drives Continuous Improvement of Pharmaceutical Water System Quality Management

A pharmaceutical water system generally consists of water production equipment, storage units, circulation pipelines and multiple points of use. Water samples taken at different locations may reflect distinct system conditions. Hence, enterprises shall formulate sampling schemes tailored to their own conditions according to water system design characteristics and quality risk assessment outcomes. The ISPE guide focuses on the representativeness of sampling points and rational design of sampling hardware, stressing that sampling locations should deliver representative samples for subsequent analysis. Meanwhile, sampling assemblies shall adopt hygienic design to reduce risks of sample contamination induced by equipment structure or operations. These requirements carry important reference value for TOC testing. Given that TOC analysis targets low-concentration organic substance detection, minor deviations during sampling may alter final test results. Standardized management must be implemented throughout the whole workflow, ranging from sampling point selection and water sample collection to laboratory analysis or on-line monitoring.

3. TOC Analytical Technology Empowers Enterprises to Optimize Water System Monitoring Systems

With the evolution of quality management concepts in the pharmaceutical industry, enterprises’ demands for water system monitoring are shifting from discrete result testing toward trend analysis and process control. As essential analytical instruments for pharmaceutical water quality monitoring, TOC analyzers generate data on water quality variation trends by measuring total organic carbon levels in water samples. At present, TOC analytical technology is extensively deployed for quality monitoring of Purified Water, Water for Injection and other high-purity water systems. In practical deployment, enterprises can select suitable testing modes in light of water system characteristics, production requirements and quality management strategies. Offline laboratory TOC testing supports routine quality confirmation, validation and analytical testing; on-line TOC monitoring enables continuous acquisition of real-time variation trends of water systems, providing data backing for process status evaluation. These two testing modes are not simple alternatives to one another. Instead, they can be rationally configured under an enterprise’s quality management system to jointly support pharmaceutical water quality control.

4. Neuronbc Delivers Multi-scenario TOC Analytical Solutions

As an enterprise specializing in the R&D and manufacturing of pharmaceutical quality testing instruments, Neuronbc continuously tracks global trends in quality control technologies for the pharmaceutical sector and commits to supplying customers with reliable total organic carbon analytical solutions. To satisfy diverse application demands, Neuronbc keeps upgrading its TOC analyzer product portfolio and builds a product lineup covering multiple testing scenarios. The company’s TOC analyzers support various detection ranges, meeting demands for high-sensitivity low-range testing as well as wide-range analysis. Furthermore, Neuronbc develops targeted testing schemes for different sample types and operating environments. Its product portfolio covers liquid sample testing, delivering customized TOC analytical solutions for various scenarios. In terms of operation modes, the instruments support both on-line monitoring and offline testing, enabling customers to select appropriate testing methods matching their process workflows, water system characteristics and quality control strategies.

Moving forward, Neuronbc will continue to track evolving quality control requirements across the global pharmaceutical industry, continuously optimize TOC analytical technologies and product performance, and deliver more precise, stable and efficient total organic carbon testing solutions for customers in pharmaceutical, life sciences and related industries. By persistent innovation in testing technologies, Neuronbc will assist more enterprises in enhancing water system quality monitoring frameworks, elevating production process management standards, and provide robust technical support for quality advancement of the global pharmaceutical industry.